Yasuaki Takeji
A5012321446- Cardiac Valve Diseases and Treatments
- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Infective Endocarditis Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Lipoproteins and Cardiovascular Health
- Antiplatelet Therapy and Cardiovascular Diseases
- Peripheral Artery Disease Management
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Function and Risk Factors
- Aortic Disease and Treatment Approaches
- Cardiac, Anesthesia and Surgical Outcomes
- Cancer, Lipids, and Metabolism
- Heart Failure Treatment and Management
- Aortic aneurysm repair treatments
- Cardiac Structural Anomalies and Repair
- Cardiovascular Effects of Exercise
- Vascular Procedures and Complications
- Stroke Rehabilitation and Recovery
- Cardiac pacing and defibrillation studies
- Blood Pressure and Hypertension Studies
- Acute Ischemic Stroke Management
- Venous Thromboembolism Diagnosis and Management
- Tendon Structure and Treatment
- Diabetes, Cardiovascular Risks, and Lipoproteins
Kanazawa University
2023-2025
Kyoto University
2018-2024
Kokura Memorial Hospital
2016-2018
Toranomon Hospital
2015
The predictive ability of patient frailty on clinical outcomes after revascularization in patients with critical limb ischemia remains largely unknown.We enrolled 643 treated endovascular therapy (N=486) or bypass surgery (N=157) January 2010 to 2016, and prospectively assessed them using a 9-level scale (CFS). Patients were divided into 3 groups according CFS levels: low (CFS level, 1-3; N=234), intermediate 4-6; N=196), high 7-9; N=213) groups. Clinical follow-up rate was 95.8% at 2 years....
Lipoprotein (a) (Lp[a]), which is a highly heritable trait, associated with coronary artery disease (CAD). However, the insight into whether association between Lp(a) and CAD differs according to family history of remains unclear. We investigated clinical data 4,512 participants who underwent serum level measurement at Kanazawa University Hospital 2008 2016. The was through logistic regression analyses. levels were significantly development (odds ratio [OR], 1.32; 95% confidence interval...
Background: Heart failure (HF) hospitalization is increasing in Japan's aging population. Current guidelines recommend daily biometric monitoring for patients with HF to facilitate early clinical intervention. However, promoting patient self-management remains insufficient. Therefore, we assessed the usefulness of LAVITA telemonitoring system, which automatically obtains and stores data via wireless devices.
Recent advances in traditional "-omics" technologies have provided deeper insights into cardiovascular diseases through comprehensive molecular profiling. Accordingly, digitalomics has emerged as a novel transdisciplinary concept that integrates multimodal information with digitized physiological data, medical imaging, environmental electronic health records, and biometric data from wearables. This digitalomics-driven augmented multiomics approach can provide more precise personalized risk...
Background It remains controversial whether long-term clinical impact of newly diagnosed atrial fibrillation (AF) in the acute phase myocardial infarction (AMI) is different from that prior AF before onset AMI. Methods and Results The current study population CREDO-Kyoto AMI (Coronary Revascularization Demonstrating Outcome Study Kyoto Acute Myocardial Infarction) Registry Wave-2 consisted 6228 patients with who underwent percutaneous coronary intervention. baseline characteristics outcomes...
Background The detailed causes of death in non–ST-segment–elevation myocardial infarction (NSTEMI) have not been adequately evaluated compared to those ST-segment elevation (STEMI). Methods study population was 6,228 AMI patients who underwent percutaneous coronary intervention (STEMI: 4,625 and NSTEMI: 1,603 patients). primary outcome all-cause death. Results Within 6 months after AMI, the adjusted mortality risk significantly different between NSTEMI STEMI (HR: 0.83, 95%CI: 0.67–1.03, P =...
The studies evaluating patients' characteristics and lipid-lowering therapy for patients with homozygous familial hypercholesterolemia (HoFH) are scarce.
Percutaneous coronary intervention for heavily calcified lesions requires rotational atherectomy (RA). Long-term clinical outcomes after drug-eluting stent (DES) implantation following (RA) remain unclear. We assessed 5-year DES RA.Methods and Results:Between March 2006 September 2011, 219 consecutive patients with treated RA, were retrospectively enrolled. The cumulative incidence of target-lesion revascularization (TLR) definite thrombosis (ST) assessed. TLR within (≤) the first year was...
Background:There are no data comparing transcatheter aortic valve implantation (TAVI) with surgical replacement (SAVR) outcomes in real clinical practice Japan.
Background: There is a scarcity of studies comparing the clinical outcomes after percutaneous coronary intervention (PCI) for women and men stratified by presentation acute syndromes (ACS) or stable artery disease (CAD).
Abstract There were no data comparing the in-hospital outcomes after transcatheter aortic valve implantation (TAVI) with those surgical replacement (SAVR) in Japan. Among consecutive patients severe AS between April 2018 and December 2020 CURRENT Registry-2, we identified 1714 who underwent (TAVI group: 1134 patients, SAVR 580 patients). Patients TAVI group much older (84.4 versus 73.6 years, P < 0.001) more often had comorbidities than group. In-hospital death rate was numerically lower...
Abstract Background Familial hypercholesterolemia (FH) is associated with atherosclerotic cardiovascular disease (ASCVD). However, the prevalence of FH among a general population remains unknown, and it unclear if other complications, including heart failure (HF) atrial fibrillation (AF). Methods Analyses were conducted on individuals without prior history using nationwide health claims database collected in JMDC Claims Database between 2005 2022 ( n = 4,126,642; median age, 44 years; 57.5%...
Transcatheter aortic valve implantation (TAVI) is criticized by some as an expensive treatment in super-elder patients with limited life expectancy. However, there a knowledge gap regarding the magnitude of clinical benefit provided TAVI comparison conservative management severe stenosis (AS) real practice, which would be important decision making for TAVI.We combined two independent registries, namely CURRENT AS and K-TAVI registries. was multicenter registry enrolling 3815 consecutive...
Background:Data evaluating the effects of acute coronary syndrome (ACS) relative to stable artery disease (CAD) on bleeding risk after percutaneous intervention (PCI) are scarce.
Background: Data on concomitant mitral regurgitation (MR) in patients with severe aortic stenosis (AS) are scarce.
Aims: Little data exists for evaluating the prevalence and patient characteristics of familial hypercholesterolemia (FH) according to latest 2022 guidelines FH published by Japan Atherosclerosis Society (JAS), which revised Achilles tendon thickness (ATT) threshold from 9.0 mm in both sexes 8.0 men 7.5 women. This study used a nationwide registry patients with acute coronary syndrome (ACS) evaluate diagnostic criteria investigate application imaging diagnosis FH.